Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1116

1.

Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.

Velasquez JC, Goeden N, Herod SM, Bonnin A.

ACS Chem Neurosci. 2016 Jan 30. [Epub ahead of print]

PMID:
26765210
2.

Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age.

Viktorin A, Lichtenstein P, Lundholm C, Almqvist C, D'Onofrio BM, Larsson H, Landén M, Magnusson PK.

Int J Epidemiol. 2016 Jan 9. pii: dyv351. [Epub ahead of print]

PMID:
26748846
3.

Letter to Editor. Use of specific SSRIs and birth defects.

Bałkowiec-Iskra E.

Psychiatr Pol. 2015;49(5):1113-1116. doi: 10.12740/PP/59304. English, Polish.

4.

Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.

Zoega H, Kieler H, Nørgaard M, Furu K, Valdimarsdottir U, Brandt L, Haglund B.

PLoS One. 2015 Dec 14;10(12):e0144474. doi: 10.1371/journal.pone.0144474. eCollection 2015.

5.

In vitro modulation of estrogen receptor activity by norfluoxetine.

Lupu D, Pop A, Cherfan J, Kiss B, Loghin F.

Clujul Med. 2015;88(3):386-90. doi: 10.15386/cjmed-476. Epub 2015 Jul 1.

6.

Effects of Citalopram on Sutural and Calvarial Cell Processes.

Durham E, Jen S, Wang L, Nasworthy J, Elsalanty M, Weinberg S, Yu J, Cray J.

PLoS One. 2015 Oct 2;10(10):e0139719. doi: 10.1371/journal.pone.0139719. eCollection 2015.

7.

SSRI use during pregnancy.

Tran H, Robb AS.

Semin Perinatol. 2015 Nov;39(7):545-7. doi: 10.1053/j.semperi.2015.08.010. Epub 2015 Oct 1.

PMID:
26428019
8.

Are the SSRI antidepressants safe in pregnancy? Understanding the debate.

Urato AC.

Int J Risk Saf Med. 2015;27(2):93-9. doi: 10.3233/JRS-150646.

PMID:
26410012
9.

Maternal Antidepressant Use and Persistent Pulmonary Hypertension of the Newborn--Reply.

Huybrechts KF, Bateman BT, Hernandez-Diaz S.

JAMA. 2015 Sep 22-29;314(12):1294. doi: 10.1001/jama.2015.10048. No abstract available.

PMID:
26393857
10.

Maternal Antidepressant Use and Persistent Pulmonary Hypertension of the Newborn.

Giannakopoulos G.

JAMA. 2015 Sep 22-29;314(12):1293-4. doi: 10.1001/jama.2015.10039. No abstract available.

PMID:
26393855
11.

Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.

Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R.

BJOG. 2015 Sep 15. doi: 10.1111/1471-0528.13582. [Epub ahead of print]

PMID:
26374234
12.

Citalopram and sertraline exposure compromises embryonic bone development.

Fraher D, Hodge JM, Collier FM, McMillan JS, Kennedy RL, Ellis M, Nicholson GC, Walder K, Dodd S, Berk M, Pasco JA, Williams LJ, Gibert Y.

Mol Psychiatry. 2015 Sep 8. doi: 10.1038/mp.2015.135. [Epub ahead of print]

PMID:
26347317
13.

Prenatal exposure to selective serotonin reuptake inhibitors (SSRI) increases aggression and modulates maternal behavior in offspring mice.

Svirsky N, Levy S, Avitsur R.

Dev Psychobiol. 2016 Jan;58(1):71-82. doi: 10.1002/dev.21356. Epub 2015 Sep 4.

PMID:
26336834
14.

Serotonin Syndrome in Pregnancy.

Roth CK, Hering SL, Campos S.

Nurs Womens Health. 2015 Aug-Sep;19(4):345-9. doi: 10.1111/1751-486X.12220.

PMID:
26264799
15.

Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.

Malm H, Sourander A, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, Artama M, Brown AS.

Am J Psychiatry. 2015 Dec 1;172(12):1224-32. doi: 10.1176/appi.ajp.2015.14121575. Epub 2015 Aug 4.

PMID:
26238606
16.

Supraphysiological hormonal status, anxiety disorders, and COMT Val/Val genotype are associated with reduced sensorimotor gating in women.

Comasco E, Hellgren C, Olivier J, Skalkidou A, Sundström Poromaa I.

Psychoneuroendocrinology. 2015 Oct;60:217-23. doi: 10.1016/j.psyneuen.2015.06.019. Epub 2015 Jul 2.

PMID:
26189199
17.

Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.

Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA; National Birth Defects Prevention Study.

BMJ. 2015 Jul 8;351:h3190. doi: 10.1136/bmj.h3190. Review.

18.

Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.

Wemakor A, Casson K, Garne E, Bakker M, Addor MC, Arriola L, Gatt M, Khoshnood B, Klungsoyr K, Nelen V, O'Mahoney M, Pierini A, Rissmann A, Tucker D, Boyle B, de Jong-van den Berg L, Dolk H.

Eur J Epidemiol. 2015 Nov;30(11):1187-98. doi: 10.1007/s10654-015-0065-y. Epub 2015 Jul 7.

PMID:
26148560
19.

Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.

Gentile S.

Expert Opin Drug Metab Toxicol. 2015;11(10):1585-97. doi: 10.1517/17425255.2015.1063614. Epub 2015 Jul 1.

PMID:
26135630
20.

Antidepressants in late pregnancy are linked to respiratory disorder in newborns, study finds.

Torjesen I.

BMJ. 2015 Jun 2;350:h2980. doi: 10.1136/bmj.h2980. No abstract available.

PMID:
26041757
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk